Aims & Scope – Pharmaceutical Nanotechnology

ISSN (Print): 2211-7385
ISSN (Online): 2211-7393

Volume 10, Issue 5, 2022

Aims & Scope

Pharmaceutical Nanotechnology publishes original manuscripts, reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale. The nanoscale is defined as a size range of below 1 µm. Scientific findings related to micro and macro systems with functionality residing within features defined at the nanoscale are also within the scope of the journal. Manuscripts detailing the synthesis, exhaustive characterisation, biological evaluation, clinical testing and/ or toxicological assessment of nanomaterials are of particular interest to the journal’s readership. Articles should be self contained, centred around a well founded hypothesis and should aim to showcase the pharmaceutical/ diagnostic implications of the nanotechnology approach. Manuscripts should aim, wherever possible, to demonstrate the in vivo impact of any nanotechnological intervention. As reducing a material to the nanoscale is capable of fundamentally altering the material’s properties, the journal’s readership is particularly interested in new characterisation techniques and the advanced properties that originate from this size reduction. Both bottom up and top down approaches to the realisation of nanomaterials lie within the scope of the journal. Read now: https://bit.ly/3Sqf61b

Most Cited Article – Pharmaceutical Lozenges: Recent Trends and Developments with an Update on Research and Patents

Author(s):Mangesh Pradeep KulkarniArun SharmaSagar TanwarParashara Bhattar VandanaSheetu WadhwaGurvinder SinghPardeep Kumar and Rajesh Kumar*

Volume 16, Issue 1, 2022

Published on: 31 January, 2022

Page: [45 – 54]

Pages: 10

DOI: 10.2174/2667387816666211231103759

Abstract

Pharmaceutical oral dosage forms are tremendously preferred by both consumers as well as pharmaceutical manufacturers owing to the plethora of benefits they offer. Lozenges (LZs) are one of the dosage forms that provide a palatable means of drug administration and have great importance with respect to their pharmaceutical applications. LZs offer additional benefits to pediatric and geriatric patients, along with people having problems associated with the gastro-intestinal tract. Dysphagia is a common problem faced by all age groups, which gives rise to the need for LZs. Moreover, the foremost merit presented by the medicated LZs includes its augmented retention time in the oral cavity that results in an enhanced bioavailability for buccal or upper gastro-intestinal disorders. Further, LZs can also be used to bypass the first-pass effect. The present review covers various aspects of LZs such as formulation, manufacturing techniques, evaluation parameters, marketed products, patents, and a compilation of research work that has been done on lozenges as a delivery system. Read more: https://bit.ly/3b9GKPf

Aims & Scope – Recent Advances in Drug Delivery and Formulation

(Formerly Recent Patents on Drug Delivery & Formulation

ISSN (Print): 2667-3878
ISSN (Online): 2667-3886

Volume 16, Issue 4, 2022

Aims & Scope

Recent Advances in Drug Delivery and Formulation publishes editorials, mini-reviews, full-length research and review articles, and short technical notes from academia, industry, and regulatory agencies worldwide. The journal’s scope covers topics related to preformulation, formulation development, manufacturing technologies, biopharmaceutics, and regulatory science of both small molecules and biomolecules. These areas include, but are not limited to pharmaceutical nanotechnology, quality by design and process analytical technology, biosimilars and biowaivers, simulation modeling. The journal also publishes guest-edited thematic issues by eminent scientists on current topics that are timely and relevant for both industry and academia. Journal’s ambition is to serve as a means for the dissemination of current fundamental and innovative science including regulatory aspects and stimulate the development of innovative technologies and products for various applications in pharmaceutical sciences and biotechnology. Read more: https://bit.ly/3vlp2iK

New Issue | Current Pharmaceutical Analysis; Volume 16 Issue 3

Untitled-2

Current Pharmaceutical Analysis

Volume 16, Issue 3

AIMS & SCOPE

Current Pharmaceutical Analysis publishes full-length/mini reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.

 

Articles from the Journal 

 

For more details on the articles, please visit HERE 

 

 

 

 

 

 

 

Advertise your event with Bentham Science

GET ADDITIONAL REGISTRATIONS TO YOUR EVENT

AND A BOOST TO YOUR ONLINE PRESENCE!

 

ADVERTISE-WITH-US.jpg

 

Representing Bentham Science, an established publisher of Scientific Journals and eBooks, we are pleased to offer our services for promoting your upcoming events, through our online and print journals, eBooks, websites and other digital platforms.

We have recently enhanced our advertising package which will help you generate a specific type of user action, such as registering to the event and will boost your online presence.

Bentham Science, an established STM publisher of over 100 scholarly journals and more than 800 books. Our publications cover 20 broad disciplines with a major focus on pharmaceutical and healthcare research. Our journals are indexed in all major indexing agencies including PubMed, Scopus, Web of Science, Clarivate Analytics etc. You can learn more about our high impact journals here.

To promote your event, we are offering online advertising services on our website and online (email campaigns and social media campaigns) channels for various scientific conferences. Our online platforms would be a good match for your conference, and will allow you to reach your target audience. More information is available on our 2019 Media Pack.

OUR ADVERTISING OFFERS

Email campaign to subscribers & contributors in the relevant field, you can custom select the audience as per your event 

*We have a list of 17,000 Editorial Board Members, 200,000 Bentham Science Contributors and 15,000 other subscribers

Our targeting criteria include:

  • Areas of Work (Oncology, Clinical Research, Pharmacology, Neuroscience, Molecular Biology, etc.)
  • Geography (USA, Europe, Asia, ME/Africa and RoW)
  • Job Titles
  • Institution Type (Academic / Commercial)

CPC Banner advertisements (First 10 clicks for FREE)

  • Banner advertisement on scholarly article pages of a relevant journal for a month (above 50 impressions per day for each banner).
  • Banner advertising on Table of Content alert to our Editorial Board Members, Subscribers and Contributors.
  • Banner advertisement on the home page of a relevant journal for a month.
  • Banner advertisement on the home page of a relevant eBook to your preference for a month.
  • Company logo on Media Partner’s section.
  • Banner advertisement under the partnering events section on Bentham Science website (Complimentary with the Package).

Social Media Promotion/Campaign (Twitter, Facebook, LinkedIn, WordPress)

In addition, we will provide you a detailed report regarding the performance of the ads, including the stats for the following:

✔Impressions

✔Clicks and CTR

✔Conversions (where possible)

You can also avail Print Advertising and Customized Email Promotion Packages with nominal costs that best suit your requirements. Visit us at: http://bit.ly/2snuJiQ

For details about the Packages and costs, please contact at hermain@benthamscience.net or faizan@benthamscience.net so that we may discuss the terms of our promotional partnership accordingly and work towards long term cooperation. If interested, we can arrange for a conference call to discuss this opportunity further.

Advertise your event with Bentham Science

BOOST YOUR ONLINE PRESENCE AND GET ADDITIONAL REGISTRATIONS TO YOUR EVENT!

ADVERTISE-WITH-US.jpg

 

We have recently enhanced our advertising package which will help you generate a specific type of user action, such as registering to the event and will boost your online presence.

Bentham Science is an established STM publisher of over 100 scholarly journals and more than 800 books. Our publications cover 20 broad disciplines with a major focus on pharmaceutical and healthcare research. Our journals are indexed in all major indexing agencies including PubMed, Scopus, Web of Science, Clarivate Analytics etc. You can learn more about our high impact journals here

To promote your event, we are offering online advertising services on our website and online (email campaigns and social media campaigns) channels for various scientific conferences. Our online platforms would be a good match for your conference, and will allow you to reach your target audience. More information is available on our 2019 Media Pack.

 

OUR ADVERTISING OFFERS

Email campaign to subscribers & contributors in the relevant field, you can custom select the audience as per your event 

*We have a list of 17,000 Editorial Board Members, 200,000 Bentham Science Contributors and 15,000 other subscribers

Our targeting criteria include:

  • Areas of Work (Oncology, Clinical Research, Pharmacology, Neuroscience, Molecular Biology, etc.)
  • Geography (USA, Europe, Asia, ME/Africa and RoW)
  • Job Titles
  • Institution Type (Academic / Commercial)

CPC Banner advertisements (First 10 clicks for FREE)

  • Banner advertisement on scholarly article pages of a relevant journal for a month (above 50 impressions per day for each banner)
  • Banner advertising on Table of Content alert to our Editorial Board Members, Subscribers and Contributors
  • Banner advertisement on the home page of a relevant journal for a month.
  • Banner advertisement on the home page of a relevant eBook to your preference.
  • Company logo on Media Partner’s section
  • Banner advertisement under the partnering events section on Bentham Science website (Complimentary with the Package)

Social Media Promotion/Campaign (Twitter, Facebook, LinkedIn, WordPress)

 

In addition, we will provide you a detailed report regarding the performance of the ads, including the stats for the following:

✔Impressions

✔Clicks and CTR

✔Conversions (where possible)

You can also avail Print Advertising and Customized Email Promotion Packages with nominal costs that best suit your requirements. For details about the Packages and costs please contact at hermain@benthamscience.net or faizan@benthamscience.net OR visit: http://bit.ly/2snuJiQ

Press Release for EurekAlert! Non-ambient conditions in the investigation and manufacturing of drug forms

Before it reaches the store shelf, a drug molecule must be prepared in a very specific way. The nature of this prepared form is of the utmost importance, as it must be robust through manufacture, packaging, transport and storage. Ultimately, this prepared drug form must have the necessary physical properties to ensure that the correct amount of drug is available to the consumer. For the successful preparation of this drug form, one often needs to produce solid samples with a controlled crystal structure and specific particle size and shape. To complicate matters, these drug crystals are often required as a part of multi-component composites. The present review summarizes how extreme pressure and temperature conditions help to achieve this goal.

cecea6487bb6533f924c57e4a5dfdfd373bb10e3aaa475caebpimgpsh_fullsize_distr

To become a drug, a pharmacologically active compound must be prepared in a specific form. This form must be robust during manufacturing, packaging, storage and transport, and must administer the correct dose to the patient. To successfully prepare a drug form, one often needs to produce solid samples with controlled crystal structure and a specific particle size and shape. To further complicate matters, these compounds, these drug particles must often end up as a part of a multi-component composite. The present review summarizes how extreme pressure and temperature conditions help achieve this highly tuned material.

In modern culture, it is very rare to find an individual who has never taken any form of medication. It must follow that the pharmaceutical industry is required to produce an enormous quantity of drug products, which can take  a variety of different forms: solutions for injections, inhalation powders, sprays, tablets, ointments, patches, amongst others. In many cases, although adopting different administration routes, different trade names are used to market the very same active pharmaceutical ingredient (API). This begs the question: if these products are the same API, is there any difference in which form is taken?

Quite simply put, yes.

Drug molecules move around the body and, by necessity, act at the molecular level. However, many of these compounds are manufactured as solids, which must either be dissolved prior to injection, or are expected to dissolve on digestion in biological fluids. In either case, dissolution is required to release individual molecules into the body.

Solid pharmaceuticals containing the same API (either pure or with additives) can have different crystal structures (polymorphism) or be amorphous. Additionally, solid particles can differ in size, shape, meso-structure, and surface charge. Within the bulk material, the spatial distribution of an API and the additives can vary. Control of these, and many other, characteristics is within the scope of materials sciences and solid-state chemistry. The chemical and material properties of their physical form therefore needs to be identified and optimized for in vivo performance, reliable manufacture and the protection of intellectual property. 

Drugs are materials, not simply molecules [1-12], By viewing drugs in this way, one can apply the knowledge of solid-state chemistry, materials science and non-ambient conditions to obtain solid forms with optimized properties. These conditions include, among others, different types of mechanical and ultrasonic treatment, hydrostatic compression, high-temperature or cryogenic spray-drying, and crystallization from supercritical solvents. Solid-state reactions (e.g. dehydration or clathrate decomposition) can be efficient in accessing metastable polymorphs or in uniformly micronizing the sample. To achieve control over drug forms and the processes used for their robust manufacturing, one needs to account for both the thermodynamic and kinetic aspects of their transformations.

The review contains over 400 references and provides a comprehensive guide through the vast ocean of publications in this field. This work is based on the personal experience of the author over several decades of active research. ###

For more information visit: http://benthamscience.com/journals/current-pharmaceutical-design/volume/22/issue/32/page/4981/

Elena V Boldyreva

Institute of Solid State Chemistry and Mechanochemistry, Siberian Branch of Russian Academy of Sciences, ul. Kutateladze, 18, Novosibirsk 630128 Russia

 

New Issue :: Pharmaceutical Nanotechnology, 4 Issue 3

Pharmaceutical Nanotechnology publishes original manuscripts, reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale. The nanoscale is defined as a size range of below 1 µm. Scientific findings related to micro and macro systems with functionality residing within features defined at the nanoscale are also within the scope of the journal. Manuscripts detailing the synthesis, exhaustive characterisation, biological evaluation, clinical testing and/ or toxicological assessment of nanomaterials are of particular interest to the journal’s readership. Articles should be self contained, centred around a well founded hypothesis and should aim to showcase the pharmaceutical/ diagnostic implications of the nanotechnology approach. Manuscripts should aim, wherever possible, to demonstrate the in vivo impact of any nanotechnological intervention. As reducing a material to the nanoscale is capable of fundamentally altering the material’s properties, the journal’s readership is particularly interested in new characterisation techniques and the advanced properties that originate from this size reduction. Both bottom up and top down approaches to the realisation of nanomaterials lie within the scope of the journal.

p

Articles from the journal Pharmaceutical Nanotechnology, Volume 4 Issue 3:

 

For details on the articles, please visit this link :: http://bit.ly/2dpfBpN

eBooks Catalog – Pharmaceutical Science

Catalog Description:

This catalog of our eBook titles in pharmaceutical sciences comprises various ebooks on advances in cancer drug targets, anti-angiogenesis drug discovery and development, anti-obesity drug discovery and development, biopolymers in drug delivery, polymeric nanomedicines, recent trends on QSAR in the pharmaceutical perceptions, reviews in pharmaceutical and biomedical analysis, opportunities and limitations for biotechnology innovation in Brazil, solubility, delivery and ADME problems of drugs and drug-candidates, the role of new technologies in medical microbiological research and diagnosis, translational animal models in drug discovery and development, treatise on ocular drug delivery, veterinary PCR diagnostics , frontiers in anti-infective drug discovery and many more.

Download here.

Recently Published Issue of The Journal: Current Pharmaceutical Analysis

Current Pharmaceutical Analysis publishes expert reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.

Following are the articles recently published in the journal Current Pharmaceutical Analysis, 11 Issue 01:

Article: The Site-specific Protonation Constants of Spectinomycin, Characterized by 1H and 15N NMR Methods  

Author(s): Mate Somlyay, Gabor Orgovan and Bela Noszal

Article: Application of Droplet Size Analysis for the Determination of the Required HLB of Lemon Oil in O/W Emulsion

Author(s): N.A. Niczinger, N. Kallai-Szabo, J. Dredan, L. Budai, M. Hajdu and I. Antal

 

Article: Electrochemical Analysis of Cyanuric Acid Using Polyaniline/CuGeO3 Nanowires as Electrode Modified Materials

Author(s): L.Z. Pei, H.D. Liu, N. Lin, Y.K. Xie and Z.Y. Cai

 

Article: Simultaneous Analysis of Losartan Potassium and its Related Impurities and Degradation Products in Tablets Using HPLC

Author(s): Shuhong Qiu, Kai Liu, Panqin Ma, Menglin Wang, Hongming Chen, Xiaochao Xu, Xiaoli Hao and Yongjun Wang

Article: LC-MS/MS Assay for Quantification of a Novel Antitubercular Molecule S006-830: Pharmacokinetic and Plasma Protein Binding Studies in Rats

Author(s): Mahendra Kumar Hidau, Yeshwant Singh, Sudhir Shahi, Poojari Mounika and Shio Kumar Singh

 

Article: Method Development & Validation of LCMS/MS for Atorvastatin and Olmesartan in Human Plasma to Trace Drug Interaction of Formulation          

Author(s): Rakesh Das and T.K. Pal

 

Article: The Effect of Albumin-genotype on Ibuprofen Displacement of Nifedipine from its Binding Sites.

Author(s): Eman Atef and Ahmed S. Mehanna

 

Article: High Sensitivity C-reactive Protein and Cardiovascular Risk Prediction

Author(s): Andreja Trpkovic, Julijana Stanimirovic, Ivana Resanovic, Petar Otasevic, Danimir Jevremovic, Radak Djordje and Esma R. Isenovic

 

Article: Analysis of Tocopherols and Tocotrienols in Pharmaceuticals and Foods: A Critical Review

Author(s): Dan Lu, Yi Yang, Yongxin Li and Chengjun Sun

For details, please visit: http://bit.ly/1BjtM3A

 

%d bloggers like this: